MARKETS / NASDAQ / AVAH
NASDAQ · SERVICES-HOME HEALTH CARE SERVICES · MID CAP

Aveanna Healthcare Holdings Inc. AVAH

7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.4B
▲ 20.2% vs FY2024
EPS · FY25
$1.05
Dividend / sh · FY25
Payout · FY25
ROE · FY25
634.7%
Net margin · FY25
9.2%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.4B
Revenue, FY2025 · full 7-year series below
Revenue Net income
0.81.62.43.22.40.2201920222025
0.81.62.43.22.40.2201920222025

9 cents of every revenue dollar became profit this year.

Per share
USD 1.05
Diluted EPS, FY2025
EPS
0.40.81.21.05201920222025
0.40.81.21.05201920222025

The company pays no cash dividend.

Profitability
634.7%
Return on equity, FY2025
ROE
200400600800634.7%201920222025
200400600800634.7%201920222025
Operating margin10.5%
Net margin9.2%
Return on assets12.2%

Each USD of equity produced 635 cents of profit this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+10.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.8%
+10.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.21B
Shares outstanding, FY2025
0.140.21201920222025
0.140.21201920222025
Change, 5 years+48.7%
Change, 10 years

The share count grew 49% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.0B
total assets, end of FY2025
Total assetsUSD 2.0B
EquityUSD 194.5M
CashUSD 193.3M
Gross debtUSD 1.3B
Net debtUSD 1.1B
Current ratio1.32×

Net debt stands at 569% of equity.

History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
2.4
2.0
1.9
1.8
1.7
1.5
1.4
Operating income $B
0.3
0.1
0.0
−0.6
−0.0
−0.0
0.0
EBITDA $B
0.3
0.1
0.0
−0.6
−0.0
0.0
0.0
Income tax $B
−0.1
0.0
−0.0
−0.0
0.0
0.0
0.0
Net income $B
0.2
−0.0
−0.1
−0.7
−0.1
−0.1
−0.1
EPS, diluted $
1.05
−0.06
−0.71
−3.57
−0.69
−0.40
−0.56
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
634.7
·
·
−210.3
−26.0
−21.3
−28.3
Shares out B
0.21
0.19
0.19
0.19
0.18
0.14
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
19 of 19
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed